Acorah Software Products - Accounts Production 16.1.300 false true 31 July 2023 1 August 2022 false 1 August 2023 31 December 2024 31 December 2024 09677130 Mr Y Bizimana Mr S Ahmad iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09677130 2023-07-31 09677130 2024-12-31 09677130 2023-08-01 2024-12-31 09677130 frs-core:CurrentFinancialInstruments 2024-12-31 09677130 frs-core:Non-currentFinancialInstruments 2024-12-31 09677130 frs-core:ComputerEquipment 2024-12-31 09677130 frs-core:ComputerEquipment 2023-08-01 2024-12-31 09677130 frs-core:ComputerEquipment 2023-07-31 09677130 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-08-01 2024-12-31 09677130 frs-core:OtherResidualIntangibleAssets 2024-12-31 09677130 frs-core:OtherResidualIntangibleAssets 2023-08-01 2024-12-31 09677130 frs-core:OtherResidualIntangibleAssets 2023-07-31 09677130 frs-core:PlantMachinery 2024-12-31 09677130 frs-core:PlantMachinery 2023-08-01 2024-12-31 09677130 frs-core:PlantMachinery 2023-07-31 09677130 frs-core:SharePremium 2024-12-31 09677130 frs-core:ShareCapital 2024-12-31 09677130 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 09677130 frs-bus:PrivateLimitedCompanyLtd 2023-08-01 2024-12-31 09677130 frs-bus:FilletedAccounts 2023-08-01 2024-12-31 09677130 frs-bus:SmallEntities 2023-08-01 2024-12-31 09677130 frs-bus:AuditExempt-NoAccountantsReport 2023-08-01 2024-12-31 09677130 frs-bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-12-31 09677130 frs-bus:Director1 2023-08-01 2024-12-31 09677130 frs-bus:Director2 2023-08-01 2024-12-31 09677130 frs-core:CurrentFinancialInstruments 1 2024-12-31 09677130 frs-core:CurrentFinancialInstruments 2 2024-12-31 09677130 frs-core:CurrentFinancialInstruments 3 2024-12-31 09677130 frs-countries:EnglandWales 2023-08-01 2024-12-31 09677130 2022-07-31 09677130 2023-07-31 09677130 2022-08-01 2023-07-31 09677130 frs-core:CurrentFinancialInstruments 2023-07-31 09677130 frs-core:Non-currentFinancialInstruments 2023-07-31 09677130 frs-core:SharePremium 2023-07-31 09677130 frs-core:ShareCapital 2023-07-31 09677130 frs-core:RetainedEarningsAccumulatedLosses 2023-07-31 09677130 frs-core:CurrentFinancialInstruments 1 2023-07-31 09677130 frs-core:CurrentFinancialInstruments 2 2023-07-31 09677130 frs-core:CurrentFinancialInstruments 3 2023-07-31
Registered number: 09677130
Med Pure Limited
Unaudited Financial Statements
For the Period 1 August 2023 to 31 December 2024
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 09677130
31 December 2024 31 July 2023
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 - 17,300
Tangible Assets 5 14,312 10,656
14,312 27,956
CURRENT ASSETS
Debtors 6 747,708 2,030,060
Cash at bank and in hand 864,403 334,415
1,612,111 2,364,475
Creditors: Amounts Falling Due Within One Year 7 (945,452 ) (1,924,974 )
NET CURRENT ASSETS (LIABILITIES) 666,659 439,501
TOTAL ASSETS LESS CURRENT LIABILITIES 680,971 467,457
Creditors: Amounts Falling Due After More Than One Year 8 (5,959 ) (11,642 )
NET ASSETS 675,012 455,815
CAPITAL AND RESERVES
Called up share capital 9 10 10
Share premium account 55,000 55,000
Profit and Loss Account 620,002 400,805
SHAREHOLDERS' FUNDS 675,012 455,815
Page 1
Page 2
For the period ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Y Bizimana
Director
19/02/2025
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Med Pure Limited is a private company, limited by shares, incorporated in England & Wales, registered number 09677130 . The registered office is Harman House, 1 George Street, Uxbridge, UB8 1QQ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Intangible Fixed Assets and Amortisation - Other Intangible
Other intangible assets are relate to software. It is amortised to over its estimated economic life of 5 years.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 25% reducing balance
Computer Equipment 25% reducing balance
2.5. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the period, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
Page 3
Page 4
3. Average Number of Employees
Average number of employees, including directors, during the year was: 7 (2023: 9)
7 9
4. Intangible Assets
Other
£
Cost
As at 1 August 2023 30,200
Disposals (20,000 )
As at 31 December 2024 10,200
Amortisation
As at 1 August 2023 12,900
Provided during the period (2,700 )
As at 31 December 2024 10,200
Net Book Value
As at 31 December 2024 -
As at 1 August 2023 17,300
5. Tangible Assets
Plant & Machinery Computer Equipment Total
£ £ £
Cost
As at 1 August 2023 927 23,089 24,016
Additions 2,420 5,093 7,513
As at 31 December 2024 3,347 28,182 31,529
Depreciation
As at 1 August 2023 167 13,193 13,360
Provided during the period 664 3,193 3,857
As at 31 December 2024 831 16,386 17,217
Net Book Value
As at 31 December 2024 2,516 11,796 14,312
As at 1 August 2023 760 9,896 10,656
6. Debtors
31 December 2024 31 July 2023
£ £
Due within one year
Trade debtors 666,211 2,012,393
Prepayments and accrued income 18,766 9,690
Deduction control 6,224 7,977
...CONTINUED
Page 4
Page 5
Alivium loan 47,520 -
Deferred credits 6,124 -
Staff loans 2,863 -
747,708 2,030,060
7. Creditors: Amounts Falling Due Within One Year
31 December 2024 31 July 2023
£ £
Trade creditors 223,044 38,307
Bank loans and overdrafts 5,152 929,522
Corporation tax 72,857 49,905
Other taxes and social security 9,060 28,055
VAT 31,657 118,814
Net wages 951 841
Other creditors 535,959 537,024
Accruals and deferred income 66,772 132,506
Directors' loan accounts - 90,000
945,452 1,924,974
8. Creditors: Amounts Falling Due After More Than One Year
31 December 2024 31 July 2023
£ £
Bank loans 5,959 11,642
9. Share Capital
31 December 2024 31 July 2023
£ £
Allotted, Called up and fully paid 10 10
Page 5